Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the category archives: OBN News

Company announcement

Isansys Wireless Patient Monitoring Technology Wins Business Award For Making a “Real Difference to People’s Lives”

Isansys Lifecare wins Best Use of Technology award at the Thames Valley Chamber of Commerce Business Awards

Read the rest of entry »

Diamond Pharma Services provided EU regulatory support to Kite Pharma Inc.

'A Diamond does not start out polished and shining, but with enough pressure, hard work and time it becomes brilliant'
Kite Pharma secures breakthrough European positive opinion for CAR-T cell cancer therapy.

Read the rest of entry »

Physiomics Trading Update

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to confirm that based on its current unaudited accounts at 20th June, it is trading ahead of market expectations for its full financial year ending 30th June 2018.

Read the rest of entry »

Aurelia Bioscience 

Aurelia Bioscience is a contract research organisation (CRO) specialising in bioassay development and compound screening.

Read the rest of entry »

Orbit Discovery raises £6.9m for peptide library

Oxford Sciences Innovation leads round into Orbit Discovery, an Oxford University spinout developing a peptide platform.

Read the rest of entry »

J A Kemp Expands in Cambridge

J A Kemp has relocated its Cambridge office today, 14 May, to larger, more modern premises on Capital Park. The firm is more than doubling its office space in Cambridge.

Read the rest of entry »

High Throughput Gene Expression Analysis Service

AMSBIO, a global provider of gene editing and personalized medicine technologies, has launched a service for high throughput gene expression analysis. 

Read the rest of entry »

Aptus Clinical - Ready for Growth

It’s only May and it has already been quite a year for Aptus Clinical. We have added several exceptional individuals to our team, given a well-deserved internal promotion and restructured to ensure efficient project management, seamless client liaison and access to our exceptional talent is at the heart of the client experience.

Read the rest of entry »

Foresight makes £3.5m growth capital investment into Mologic

Investment to support launch of sepsis, COPD and infectious disease diagnostics and international expansion of Contract Research business.

Read the rest of entry »

Chronos Therapeutics Announces Positive Pre-Clinical Proof of Concept Studies for its Orexin-1 Antagonist Project Initially Targeting Binge Eating Disorder

Chronos Therapeutics Ltd (Chronos) the private biotech company focused on ageing diseases, brain and nervous system disorders, announced today that the lead compound in its addiction programme, CT-010018 an orexin-1 antagonist, demonstrated positive pre-clinical proof of concept (POC) results in an in vivo model of binge eating disorder (BED).

Read the rest of entry »

Pages: Previous1234567...16NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.